Director of Hematopathology Professor, Department of Pathology, OHSU
Pathology
Dr. Rita M. Braziel, MD
|
|
Give Review
Rita Braziel is an expert in the field of Pathology. He went to University of New Mexico School of Medicine. University of New Mexico School of Medicine is ranked 83/35 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Rita Braziel has written publications. He has 100 publications published with PubMed. The lastest paper is: 'Nodular sclerosing Hodgkin disease with primary manifestation in the orbit.' He accepts all Medicare patients.
Publications
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggresive B-cell lymphoma.
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymph...
- Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
- Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell lymphoma.
- A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP + 131Iodine--Tositumomab.
- Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
- Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell Lymphoma.
- Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin...
- Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
- MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-Cell Lymphoma Treated with CHOP-like therapy and Rituximab.
- Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues.
- Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
- Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
- Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
- Immunophenotypic variations of Burkitt lymphoma.
- Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
- A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
- Hypothesis: sarcoidosis is a STAT1-mediated disease.
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
- Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay.
- Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1.
- Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
- Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal delet...
- Proteomic profiling of mature CD10+ B-cell lymphomas.
- Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
- B-Cells in ocular adnexal lymphoproliferative lesions express B-cell attracting chemokine 1 (CXCL13).
- Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
- Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis.
- BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
- Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless...
- Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations.
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
- A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Grou...
- Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.
- Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
- Molecular diagnostics.
- Detection of bcl-2/J(H) translocation by polymerase chain reaction: a summary of the experience of the Molecular Oncology Survey of the College of American Pathologist.
- Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience.
- Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays.
- Fine-needle aspiration biopsy of anaplastic large cell lymphoma, small cell variant with prominent plasmacytoid features: case report.
- Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens.
- Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
- Cellular basis for the elevated gallium-67 computed lung index in a rheumatoid lung patient.
- Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without rad...
- Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation.
- Toxicity of recombinant human interleukin-2 in rats following intravenous infusion.
- Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series.
- The toxicity of recombinant human interleukin-2 in rats following intravenous infusion.
- Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations.
- Human plague in New Mexico: report of three autopsied cases.
- The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.
- Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
- Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias.
- Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
- Gene rearrangements in malignant lymphomas.
- Atypical human T-cell lymphotropic virus type-I-associated T-cell lymphoma in a low-prevalence Alaska Native population. Implications for disease surveillance.
- Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
- In vivo administration of purified Jurkat-derived interleukin 2 in mice.
- In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia.
- Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma.
- Induction of immunoglobulin secretion in follicular non-Hodgkin's lymphomas: role of immunoregulatory T cells.
- Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features.
- Colonic lymphoma in the transplant patient.
- Gastrointestinal involvement in Langerhans cell histiocytosis (histiocytosis X): diagnosis by rectal biopsy.
- Transient myeloproliferative disorder of the Down type in the normal newborn.
- T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome.
- Mistaken diagnoses of Hodgkin's disease.
- Absence of Epstein-Barr virus in lymphomatoid papulosis. An immunohistochemical and in situ hybridization study.
- The in-vitro response of CD2-positive acute myelogenous leukemia to proliferation and differentiation inducing agents.
- Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis.
- Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib ...
- Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples.
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.
- Nodular sclerosing Hodgkin disease with primary manifestation in the orbit.
- Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
- SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.
- Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoc...
- Array-based DNA methylation profiling in follicular lymphoma.
- Stromal gene signatures in large-B-cell lymphomas.
- Pathology: a marker for monoclonality of T-cell malignancy.
- Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in fo...
- FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248).
- Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
- Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma.
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.
- Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin''s lymphoma: five-year follow-up o...
- Molecular diagnosis of Burkitt''s lymphoma.
- Detection of clonal IGH gene rearrangements: summary of molecular oncology surveys of the College of American Pathologists.
- Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
- Expression of vascular endothelial growth factor and its receptors in rosacea.
- Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt''s lymphoma.
- Clinical laboratory reports in molecular pathology.
- Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator prom...
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
- Oncogenically active MYD88 mutations in human lymphoma.
Schools
University of New Mexico Main Campus
University Hospital
University Of Nm School Of Med
Doctors Specialties
- Pathology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Cigna
- Commercial Insurance Company
- First Choice Health PPO
- First Health (Coventry Health Care) PPO
- Health Plan of Oregon PPO
- HealthNet
- Medicare Advantage PFFS
- Humana
- Kaiser Permanente
- Medicaid
- Medicare MCR
- ODS Health Plan
- Preferred PSN
- Heritage Plus
- Heritage Signature
- Preferred PPO
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of New Mexico -
University of New Mexico School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265447759 |
| Last Name Of The Provider | BRAZIEL |
| First Name Of The Provider | RITA |
| View All |
Similar Doctors
|
|
Dr. Frances V. Verzosa, MD |
|
|
Dr. Julie D. Kingery, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence A. Dworkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mona Labar, MD |
|
|
Dr. Barbara J. Armstrong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ken M. Gatter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane C. Morrison, MD
This Doctor is OpenDoctor Recommended.
|